Noemie Gensous
Bordeaux, 33000, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
From CD20 to CD19: the shift from cautious to deeper B-cell depletion in autoimmune diseases.
Journal: The Journal of allergy and clinical immunology
Published: May 26, 2026
Healthy ageing: The struggle for maintaining T cells young.
Journal: International immunology
Published: May 19, 2026
Scurvy, an enduring mimicker and diagnostic dilemma in adults: A review of the 280 relevant published cases in the twenty-first century.
Journal: Clinical nutrition (Edinburgh, Scotland)
Published: January 29, 2026
Janus kinase and calcineurin-inhibitor combination in anti-MDA5 dermatomyositis: No significant survival benefit but reassuring safety profile.
Journal: Journal of internal medicine
Published: November 24, 2025
Pharmacology considerations for managing pregnancy in women with systemic lupus erythematosus.
Journal: Expert review of clinical pharmacology
Published: October 09, 2025
Giant hepatic hemangioma: A rare cause of fever of unkonwn origin fever
Journal: La Revue de medecine interne
Published: July 16, 2025
Stool Screening for Campylobacter Species in Hypogammaglobulinemic Patients Receiving Immunoglobulin Therapy.
Journal: Journal of clinical immunology
Published: May 31, 2025
Cluster analysis reveals the clinical spectrum of Erdheim-Chester disease.
Journal: Leukemia
Published: February 11, 2025
Place of chitotriosidase as a serum biomarker of sarcoidosis: A narrative review of the literature
Journal: La Revue de medecine interne
Published: December 30, 2024
Prognosis of essential mixed cryoglobulinemia and connective tissue disease-related cryoglobulinemia after rituximab-induced remission.
Journal: Rheumatology (Oxford, England)
Published: November 09, 2024
Preventing hyperhomocysteinemia using vitamin B6 supplementation in Givosiran-treated acute intermittent porphyria: Highlights from a case report and brief literature review.
Journal: Molecular genetics and metabolism reports
Published: December 20, 2023
Anifrolumab: first biologic approved in the EU not restricted to patients with a high degree of disease activity for the treatment of moderate to severe systemic lupus erythematosus.
Journal: Expert review of clinical immunology
Published: October 06, 2023
Last Updated: 09/26/2026